Cargando…

SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients

Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauridsen, Rikke Kragh, Sommer, Lea M., Johansen, Helle Krogh, Rindzevicius, Tomas, Molin, Søren, Jelsbak, Lars, Engelsen, Søren Balling, Boisen, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368648/
https://www.ncbi.nlm.nih.gov/pubmed/28349938
http://dx.doi.org/10.1038/srep45264
_version_ 1782517966681669632
author Lauridsen, Rikke Kragh
Sommer, Lea M.
Johansen, Helle Krogh
Rindzevicius, Tomas
Molin, Søren
Jelsbak, Lars
Engelsen, Søren Balling
Boisen, Anja
author_facet Lauridsen, Rikke Kragh
Sommer, Lea M.
Johansen, Helle Krogh
Rindzevicius, Tomas
Molin, Søren
Jelsbak, Lars
Engelsen, Søren Balling
Boisen, Anja
author_sort Lauridsen, Rikke Kragh
collection PubMed
description Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The P. aeruginosa biomarker hydrogen cyanide (HCN) contains a triple bond, which is utilized in this study because of the resulting characteristic C≡N peak at 2135 cm(−1) in a Raman spectrum. The Raman signal was enhanced by surface-enhanced Raman spectroscopy (SERS) on a Au-coated SERS substrate. After long-term infection, a mutation in the patho-adaptive lasR gene can alter the expression of HCN, which is why it is sometimes not possible to detect HCN in the breath of chronically infected patients. Four P. aeruginosa reference strains and 12 clinical P. aeruginosa strains isolated from CF children were evaluated, and HCN was clearly detected from overnight cultures of all wild type-like isolates and half of the later isolates from the same patients. The clinical impact could be that P. aeruginosa infections could be detected at an earlier stage, because daily breath sampling with an immediate output could be possible with a point-of-care SERS device.
format Online
Article
Text
id pubmed-5368648
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53686482017-03-30 SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients Lauridsen, Rikke Kragh Sommer, Lea M. Johansen, Helle Krogh Rindzevicius, Tomas Molin, Søren Jelsbak, Lars Engelsen, Søren Balling Boisen, Anja Sci Rep Article Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The P. aeruginosa biomarker hydrogen cyanide (HCN) contains a triple bond, which is utilized in this study because of the resulting characteristic C≡N peak at 2135 cm(−1) in a Raman spectrum. The Raman signal was enhanced by surface-enhanced Raman spectroscopy (SERS) on a Au-coated SERS substrate. After long-term infection, a mutation in the patho-adaptive lasR gene can alter the expression of HCN, which is why it is sometimes not possible to detect HCN in the breath of chronically infected patients. Four P. aeruginosa reference strains and 12 clinical P. aeruginosa strains isolated from CF children were evaluated, and HCN was clearly detected from overnight cultures of all wild type-like isolates and half of the later isolates from the same patients. The clinical impact could be that P. aeruginosa infections could be detected at an earlier stage, because daily breath sampling with an immediate output could be possible with a point-of-care SERS device. Nature Publishing Group 2017-03-28 /pmc/articles/PMC5368648/ /pubmed/28349938 http://dx.doi.org/10.1038/srep45264 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Lauridsen, Rikke Kragh
Sommer, Lea M.
Johansen, Helle Krogh
Rindzevicius, Tomas
Molin, Søren
Jelsbak, Lars
Engelsen, Søren Balling
Boisen, Anja
SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title_full SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title_fullStr SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title_full_unstemmed SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title_short SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
title_sort sers detection of the biomarker hydrogen cyanide from pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368648/
https://www.ncbi.nlm.nih.gov/pubmed/28349938
http://dx.doi.org/10.1038/srep45264
work_keys_str_mv AT lauridsenrikkekragh sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT sommerleam sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT johansenhellekrogh sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT rindzeviciustomas sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT molinsøren sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT jelsbaklars sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT engelsensørenballing sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients
AT boisenanja sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients